292 related articles for article (PubMed ID: 29369517)
1. Causes and timing of end-stage renal disease after living kidney donation.
Matas AJ; Berglund DM; Vock DM; Ibrahim HN
Am J Transplant; 2018 May; 18(5):1140-1150. PubMed ID: 29369517
[TBL] [Abstract][Full Text] [Related]
2. Risk of ESRD in prior living kidney donors.
Wainright JL; Robinson AM; Wilk AR; Klassen DK; Cherikh WS; Stewart DE
Am J Transplant; 2018 May; 18(5):1129-1139. PubMed ID: 29392849
[TBL] [Abstract][Full Text] [Related]
3. GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.
Matas AJ; Vock DM; Ibrahim HN
Am J Transplant; 2018 Mar; 18(3):625-631. PubMed ID: 28980397
[TBL] [Abstract][Full Text] [Related]
4. A Case-Based Analysis of Whether Living Related Donors Listed for Transplant Share ESRD Causes with Their Recipients.
Matas AJ; Hays RE; Ibrahim HN
Clin J Am Soc Nephrol; 2017 Apr; 12(4):663-668. PubMed ID: 28249957
[TBL] [Abstract][Full Text] [Related]
5. Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.
Massie AB; Holscher CM; Henderson ML; Fahmy LM; Thomas AG; Al Ammary F; Getsin SN; Snyder JJ; Lentine KL; Garg AX; Segev DL
JAMA Surg; 2020 Mar; 155(3):e195472. PubMed ID: 31968070
[TBL] [Abstract][Full Text] [Related]
6. Obesity increases the risk of end-stage renal disease among living kidney donors.
Locke JE; Reed RD; Massie A; MacLennan PA; Sawinski D; Kumar V; Mehta S; Mannon RB; Gaston R; Lewis CE; Segev DL
Kidney Int; 2017 Mar; 91(3):699-703. PubMed ID: 28041626
[TBL] [Abstract][Full Text] [Related]
7. Hypertension after kidney donation: Incidence, predictors, and correlates.
Sanchez OA; Ferrara LK; Rein S; Berglund D; Matas AJ; Ibrahim HN
Am J Transplant; 2018 Oct; 18(10):2534-2543. PubMed ID: 29498216
[TBL] [Abstract][Full Text] [Related]
8. Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.
Holscher CM; Ishaque T; Garonzik Wang JM; Haugen CE; DiBrito SR; Jackson KR; Muzaale AD; Massie AB; Al Ammary F; Ottman SE; Henderson ML; Segev DL
Am J Transplant; 2018 Nov; 18(11):2804-2810. PubMed ID: 30086198
[TBL] [Abstract][Full Text] [Related]
9. Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.
Anjum S; Muzaale AD; Massie AB; Bae S; Luo X; Grams ME; Lentine KL; Garg AX; Segev DL
Am J Transplant; 2016 Dec; 16(12):3540-3547. PubMed ID: 27287605
[TBL] [Abstract][Full Text] [Related]
10. Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease.
Muzaale AD; Massie AB; Anjum S; Liao C; Garg AX; Lentine KL; Segev DL
Am J Transplant; 2016 Dec; 16(12):3532-3539. PubMed ID: 27172445
[TBL] [Abstract][Full Text] [Related]
11. Long-term Mortality Risks Among Living Kidney Donors in Korea.
Kim Y; Yu MY; Yoo KD; Jeong CW; Kim HH; Min SI; Ha J; Choi Y; Ko AR; Yun JM; Park SM; Yang SH; Kim DK; Oh KH; Joo KW; Ahn C; Kim YS; Lee H
Am J Kidney Dis; 2020 Jun; 75(6):919-925. PubMed ID: 31866225
[TBL] [Abstract][Full Text] [Related]
12. Risk of end-stage renal disease following live kidney donation.
Muzaale AD; Massie AB; Wang MC; Montgomery RA; McBride MA; Wainright JL; Segev DL
JAMA; 2014 Feb; 311(6):579-86. PubMed ID: 24519297
[TBL] [Abstract][Full Text] [Related]
13. End-stage renal disease after kidney donation: a single-center experience.
Rosenblatt GS; Nakamura N; Barry JM
Transplant Proc; 2008 Jun; 40(5):1315-8. PubMed ID: 18589095
[TBL] [Abstract][Full Text] [Related]
14. Renal Function Profile in White Kidney Donors: The First 4 Decades.
Ibrahim HN; Foley RN; Reule SA; Spong R; Kukla A; Issa N; Berglund DM; Sieger GK; Matas AJ
J Am Soc Nephrol; 2016 Sep; 27(9):2885-93. PubMed ID: 26888476
[TBL] [Abstract][Full Text] [Related]
15. Impact of the individualized risks of end-stage renal disease on living kidney donor selection.
Nguyen QL; Merville P; Couzi L
Nephrol Dial Transplant; 2018 Dec; 33(12):2245-2252. PubMed ID: 29846692
[TBL] [Abstract][Full Text] [Related]
16. Renal Consequences of Diabetes After Kidney Donation.
Ibrahim HN; Berglund DM; Jackson S; Vock DM; Foley RN; Matas AJ
Am J Transplant; 2017 Dec; 17(12):3141-3148. PubMed ID: 28681494
[TBL] [Abstract][Full Text] [Related]
17. The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.
Vock DM; Helgeson ES; Mullan AF; Issa NS; Sanka S; Saiki AC; Mathson K; Chamberlain AM; Rule AD; Matas AJ
BMC Nephrol; 2023 May; 24(1):121. PubMed ID: 37127560
[TBL] [Abstract][Full Text] [Related]
18. Increasing Use of the Expanded Criteria for Living Kidney Donation and Good Outcomes of Living Kidney Donors in Korea.
Lim HJ; Jambaldorj E; Lee Y; Kang SS; Koo TY; Ahn C; Yang J
Transplant Proc; 2016 Sep; 48(7):2407-2411. PubMed ID: 27742310
[TBL] [Abstract][Full Text] [Related]
19. The landscape of international living kidney donation in the United States.
Al Ammary F; Thomas AG; Massie AB; Muzaale AD; Shaffer AA; Koons B; Qadi MA; Crews DC; Garonzik-Wang J; Fang H; Brennan DC; Lentine KL; Segev DL; Henderson ML
Am J Transplant; 2019 Jul; 19(7):2009-2019. PubMed ID: 30615253
[TBL] [Abstract][Full Text] [Related]
20. Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.
Holscher CM; Bae S; Thomas AG; Henderson ML; Haugen CE; DiBrito SR; Muzaale AD; Garonzik Wang JM; Massie AB; Lentine KL; Segev DL
Transplantation; 2019 Jun; 103(6):1216-1223. PubMed ID: 30247449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
